Drug Database
Back to search

Finland· FI-REL-REL62646

Gynover

A lactobacillus product containing lactobacillus gasseri dsm 14869 + lactobacillus rhamnosus dsm 14870, registered in Finland by Verman Ab Oy. The same ATC class is registered in 8 of our 19 countries.

ATC G01AX14

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedGynoverATCG01AX14REGISTER NO.FI-REL-REL62646PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lactobacillus gasseri dsm 14869 + lactobacillus rhamnosus dsm 14870Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lactobacillus is registered in 8 of 19 countries.

Countries holding a registration under ATC G01AX14 (lactobacillus), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose
Search lactobacillus products by name

Lactobacillus · ATC G01AX14

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Lactobacillus gasseri DSM 14869 + Lactobacillus rhamnosus DSM 14870
Manufacturer
Verman Ab Oy
Country
Finland (FI)
ATC code
G01AX14
ATC class
Lactobacillus
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under G01AX14

Lactobacillus, as other registers publish it.

All lactobacillus products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f320469b-fa70-4780-b515-b2a4ffc8218f
GET /v1/drugs/f320469b-fa70-4780-b515-b2a4ffc8218f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "emätinpuikko, kapseli, kova",
  "route": "Emättimeen",
  "ddd_unit": null,
  "strength": "10E8 CFU / 10E8 CFU",
  "atc_label": "lactobacillus",
  "ma_number": "43578",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL62646",
  "authorised_at": "2025-02-24"
}
API referenceMCP serverPlans

See everything about lactobacillus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console